Biote Corp. Class A Common Stock (BTMD) is a publicly traded Healthcare sector company. As of July 22, 2026, BTMD trades at $2.41 with a market cap of $76.44M and a P/E ratio of 2.76. BTMD moved -6.75% today. Year to date, BTMD is -9.62%; over the trailing twelve months it is -42.96%. Its 52-week range spans $1.27 to $6.98. Analyst consensus is strong buy with an average price target of $2.75. Rallies surfaces BTMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for BTMD combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.41 |
| Market Cap | $76.44M |
| P/E Ratio | 2.76 |
| EPS | $0.86 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.98 |
| 52-Week Low | $1.27 |
| Volume | 41.06K |
| Avg Volume | 0 |
| Revenue (TTM) | $192.22M |
| Net Income | $31.60M |
| Gross Margin | 0.00% |
3 analysts cover BTMD: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $2.75.